Pharmaceutical compositions and methods for treating Alzheimer's disease
- 专利权人:
- LA PharmaTech Inc.
- 发明人:
- Jianmin Wang,Geping Cui
- 申请号：
- US16418614
- 公开号：
- US10639315B1
- 申请日:
- 2019.05.21
- 申请国别(地区):
- US
- 年份:
- 2020
- 代理人:
- 摘要：
- A pharmaceutical composition containing the therapeutically active ingredients of azelastine or a pharmaceutically acceptable salt of azelastine and donepezil or rivastigmine or galantamine or a pharmaceutically acceptable salt of thereof is disclosed. A method of using the pharmaceutical composition for treating patients suffering from mental, behavioral, cognitive disorders is also disclosed.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- NOVEL PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S AND HUNTINGTON'S DISEASE
- New association between 4-{ 3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy} benzamide and an acetylcholinesterase inhibitor, and pharmaceutical compositions containing it
- ΒΕΛΤΙΩΣΗ ΚΑΙ ΘΕΡΑΠΕΥΤΙΚΗ ΑΞΙΟΠΟΙΗΣΗ ΤΗΣ ΣΥΜΠΤΩΜΑΤΙΚΗΣ ΑΝΤΙΜΕΤΩΠΙΣΗΣ ΤΗΣ ΑΣΘΕΝΕΙΑΣ ΤΟΥ ALZHEIMER ΜΕ RIVASTIGMINE, GALANTAMINE Ή DONEPEZIL, ΔΙΑ ΕΠΙΛΕΓΜΕΝΩΝ ΑΜΙΝΟΤΕΤΡΑΫΔΡΟΦΟΥΡΑΝΙΩΝ ΠΟΥ ΔΡΟΥΝ ΣΑΝ ΜΙΚΤΟΙ ΣΙΓΜΑ-1/ ΜΟΥΣΚΑΡΙΝΙΚΟΙ ΠΡΟΣΔΕΤΕΣ
- OPTIMIZATION AND THERAPEUTIC VALORIZATION OF THE SYMPTOMATIC TREATMENT OF ALZHEIMER'S DISEASE WITH RIVASTIGMINE, GALANTAMINE OR DONEPEZIL, BY SELECTED AMINOTETRAHYDROFURANS ACTING AS MIXED SIGMA-1 / MUSCARINIC LIGANDS
- ADMINISTRATION TRANSDERMIQUE CONTENANT DE LA GALANTAMINE OU SES SELS
